**Job Description**

The Quantitative Pharmacology and Pharmacometrics (QP2) department drives model-informed drug discovery and development (MIDD) to routinely enable efficient drug discovery/development and/or regulatory decisions. The Pharmacometrics group within QP2 brings an experienced leadership team, deep modeling expertise and state-of-the-art modeling approaches across multiple therapeutic areas and modalities to drive portfolio impact from discovery through life-cycle management. The team is externally visible and continues to be at the leading edge of building innovative state-of-the-art tools together with applying AI/ML techniques to drive pipeline impact. As we enter a new era of AI-driven drug development, our mission is to amplify MIDD through cutting-edge AI, advanced analytics, and automation. With AI/ML now integral to decision-making at our Company, this role gives the Director the opportunity to shape pipeline impact and lead a talented team of pharmacomet...